Fondaparinux Sodium

Overview

Categories

Primary Characterstics

Indications

Back to top

Pharmacokinetics

Back to top

Contraindications

Back to top

Drug Interactions

Back to top

Side Effects

Back to top

Dosage

Fondaparinux Sodium's dosage details are as follows:
Dose Single Dose Frequency Route Instructions

Adult Dosage

2.5 mg2.5 (2.5)24 hourlySCDVT Prophylaxis: After hemostasis is established, give the initial dose 6 to 8 h after surgery. Usual duration of therapy is 5 to 9 days (up to 11 days following hip or knee replacement surgery or up to 10 days following abdominal surgery). An extended prophylaxis course of up to 24 additional days (up to 32 days total) is recommended following hip fracture surgery.
5 mg5 (5)24 hourlySCAcute DVT and Acute PE Treatment: Subcutaneous 5 mg if body weight less than 50 kg, 7.5 mg if body weight 50 to 100 kg, and 10 mg if body weight more than 100 kg, given once daily. Continue treatment for at least 5 days and until a therapeutic oral anticoagulant effect is established (INR 2 to 3). Initiate coadministration of warfarin as soon as possible, usually within 72 h. Usual duration of therapy is 5 to 9 days (up to 26 days).

Paedriatic Dosage (20kg)

No data regarding the Paedriatic dosage details of Fondaparinux Sodium is available.

Neonatal Dosage (3kg)

No data regarding the neonatal dosage details of Fondaparinux Sodium is available.

High Risk Groups

Back to top

Warning / Precautions

Back to top

Storage Conditions

Back to top

Interference in Pathology

Back to top

Brands / Trade Names of Fondaparinux Sodium

Back to top

Manufacturers of Fondaparinux Sodium in Pakistan

Back to top

Previous Drug Generic - Next Drug Generic